## CVS: CVS Health Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -1.3% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Wedge Capital Management L L P NC Lowers Stake in CVS Health Corporation $CVS**
- Source: MarketBeat | 20251221T123559 | Somewhat-Bearish | Relevance: 96%
- Wedge Capital Management L L P NC reduced its stake in CVS Health Corporation by 19.7% in the third quarter, selling 95,782 shares and ending with 390,797 shares valued at $29.46 million. Despite this, several major institutional investors increased their positions, with hedge funds and institutional investors collectively owning about 80.66% of the company. CVS Health reported strong Q3 earnings, beating analyst expectations, and received a consensus "Moderate Buy" rating with a $94.67 price target from analysts.

**2. Here's what stores are open, and which ones are closed, on Christmas**
- Source: ABC News | 20251222T160900 | Neutral | Relevance: 75%
- Many major retailers and grocery stores across the U.S. will be closed on Christmas Day, though some will have modified hours or select locations open. It is advisable for customers to check specific store hours online or call ahead before visiting. This article provides a comprehensive list of which popular stores will be open or closed on Christmas Day.

**3. Is Walmart, Target open on Christmas? What stores are open, closed in Mass. on Dec. 25**
- Source: MassLive | 20251222T200829 | Neutral | Relevance: 75%
- This article provides information on which major retail stores will be open or closed in Massachusetts on Christmas Day. Most large retailers like Walmart, Target, and Costco will be closed, while many convenience and food service establishments like CVS, Walgreens, Starbucks, and McDonald's will have varied or reduced hours, advising customers to check local listings. Several other major stores, including ALDI, Home Depot, and Whole Foods, are also confirmed to be closed for the holiday.

**4. Virtual Care Market to Reach US$ 72.73 Billion by 2033 at 13.2% CAGR; North America Leads with 40% Share - Key Players: Teladoc Health, CVS Health, Oracle**
- Source: openPR.com | 20251222T090925 | Somewhat-Bullish | Relevance: 74%
- The Virtual Care Market is projected to reach US$ 72.73 billion by 2033, growing at a CAGR of 13.2% from US$ 24.01 billion in 2024. North America currently leads the market with a 40% share, driven by strong telehealth adoption and supportive policies. Key players like Teladoc Health, CVS Health, and Oracle are driving market expansion through technological advancements and integrated care models, despite challenges such as data privacy concerns and regulatory complexities.

**5. Morgan Stanley asks: Is UNH "the CVS of 2026"?**
- Source: Investing.com | 20251221T090834 | Neutral | Relevance: 73%
- Morgan Stanley questions whether UnitedHealth Group (UNH) is adopting a strategy similar to CVS Health, prioritizing profitability over membership growth for 2026. This comes as UNH aggressively reprices benefits and targets a reduction of Medicare Advantage members to address profitability pressures. The firm anticipates a recovery in Medicare Advantage margins for UNH, despite potential underestimation by investors regarding the extent of benefit cuts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | JP Morgan | $101 | $93 | +9% |
| 2025-12-12 | Bernstein | $87 | $86 | +1% |
| 2025-12-10 | Truist Securiti | $98 | $95 | +3% |
| 2025-12-10 | Piper Sandler | $101 | $99 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | JP Morgan | main | Overweight |
| 2025-12-12 | Bernstein | main | Market Perform |
| 2025-12-10 | Truist Securiti | main | Buy |
| 2025-12-10 | Piper Sandler | reit | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 11 ($1.40M) |
| Sells | 4 ($2.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Blackrock Inc.: 9.4% (-2.3%)
- Vanguard Group Inc: 9.4% (-1.3%)
- Dodge & Cox Inc.: 5.8% (-0.1%)
- JPMORGAN CHASE & CO: 5.6% (+162.5%)
- Capital World Invest: 5.4% (+2.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.0% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 10 raises (avg +6%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.55 indicates undervaluation relative to growth. Analyst sentiment positive (10 raises, avg +6%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $99.1B |
| Beta | 0.48 |
| 52W Range | $43.65 - $85.15 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.55 |
| Forward P/E | 10.9 |
| Current P/E | 11.7 |
| YoY Growth | 7.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.8% to -1.3% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.3pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.11x) but short-term weakness (below SMA20). RSI neutral at 49. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.26% (CS: 40) | Neutral |
| RSI_14 | 49.0 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 0.997x | Below |
| vs SMA50 | 0.987x | Below |
| vs SMA200 | 1.107x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $78.03
- **Stop Loss:** $74.47 (4.6% risk)
- **Target:** $81.59 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 337
- **Position Value:** $26,296.11
- **Portfolio %:** 26.30%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-11 (Est: $0.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.36 | $1.60 | +17.9% |
| 2025Q2 | $1.46 | $1.81 | +23.8% |
| 2025Q1 | $1.67 | $2.25 | +34.5% |
| 2024Q4 | $0.92 | $1.19 | +29.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*